These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15682825)

  • 21. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP; Bouvard M; Stinus L
    Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct effects of the serotonin-noradrenaline reuptake inhibitors milnacipran and venlafaxine on rat pineal monoamines.
    Muneoka K; Kuwagata M; Ogawa T; Shioda S
    Neuroreport; 2015 Jun; 26(9):510-4. PubMed ID: 26016648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.
    Szabo ST; Blier P
    Brain Res; 2001 Dec; 922(1):9-20. PubMed ID: 11730697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo.
    Mateo Y; Ruiz-Ortega JA; Pineda J; Ugedo L; Meana JJ
    Neuropharmacology; 2000 Aug; 39(11):2036-43. PubMed ID: 10963747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats.
    Obata H; Kimura M; Nakajima K; Tobe M; Nishikawa K; Saito S
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1059-65. PubMed ID: 20558774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
    Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Tanaka T; Masui T; Koyama T
    Eur J Pharmacol; 2008 Apr; 584(2-3):285-90. PubMed ID: 18336812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of long-term administration of the antidepressant drug milnacipran on serotonergic and noradrenergic neurotransmission in the rat hippocampus.
    Weiss M; Blier P; de Montigny C
    Life Sci; 2007 Jun; 81(2):166-76. PubMed ID: 17568622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of locus coeruleus neurons by serotonin at high doses.
    Chiu TH; Yang YR; Yang JJ; Chen CL
    Chin J Physiol; 1995; 38(3):153-7. PubMed ID: 8846724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J
    Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by ethanol of excitatory amino acid receptors in rat locus coeruleus neurons in vitro.
    Nieber K; Poelchen W; Sieler D; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):299-308. PubMed ID: 9550302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locus coeruleus activity in perinatally protein-deprived rats: effects of fluoxetine administration.
    Sodero AO; Valdomero A; Cuadra GR; Ramírez OA; Orsingher OA
    Eur J Pharmacol; 2004 Oct; 503(1-3):35-42. PubMed ID: 15496293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats.
    Bel N; Artigas F
    Neuropsychopharmacology; 1999 Dec; 21(6):745-54. PubMed ID: 10633480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical pharmacology of milnacipran.
    Briley M; Prost JF; Moret C
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():9-14. PubMed ID: 8923122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Milnacipran inhibits itch-related responses in mice through the enhancement of noradrenergic transmission in the spinal cord.
    Andoh T; Gotoh Y; Kuraishi Y
    J Pharmacol Sci; 2013; 123(2):199-202. PubMed ID: 24096836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACS chemical neuroscience molecule spotlight on savella.
    Hopkins CR
    ACS Chem Neurosci; 2010 May; 1(5):345. PubMed ID: 22778830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Milnacipran, a serotonin and norepinephrine reuptake inhibitor, induces appetite-suppressing effects without inducing hypothalamic stress responses in mice.
    Nonogaki K; Nozue K; Kuboki T; Oka Y
    Am J Physiol Regul Integr Comp Physiol; 2007 May; 292(5):R1775-81. PubMed ID: 17218444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
    Gervasoni D; Panconi E; Henninot V; Boissard R; Barbagli B; Fort P; Luppi PH
    Pharmacol Biochem Behav; 2002 Oct; 73(3):557-63. PubMed ID: 12151030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
    Bourin M; Masse F; Dailly E; Hascoët M
    Pharmacol Biochem Behav; 2005 Jul; 81(3):645-56. PubMed ID: 15961146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain.
    Leo RJ; Brooks VL
    Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.